What SEBI published and why it matters

SEBI’s AIF page lists three important 2026 items for funds: the Master Circular for AIFs dated 3 June 2026, the consultation paper dated 30 June 2026 on rationalising investor consent and conflicted transactions, and the GARUDA green-channel mechanism dated 30 July 2026 for processing placement memoranda. These developments show a clear regulatory theme: faster fund operations where possible, but cleaner governance and investor consent where conflicts exist.

For founders raising from Category I or Category II AIFs, the law applies to the fund. The friction, however, can land on the startup. If the fund manager needs LP/investor consent or trustee approval before investing, extending tenure, warehousing a deal, restructuring, selling to an affiliate or using a conflicted vehicle, the founder’s round timeline can change.

What the consultation is trying to solve

AIF regulations and fund documents contain several consent triggers. Market practice has not always been uniform on how investor consent is collected, what percentage threshold applies, whether silence can count, and which transactions should be treated as conflicted. SEBI’s consultation paper is aimed at rationalising this framework.

Where startups feel AIF consent issues

A startup usually experiences AIF governance through delays or additional conditions. The term sheet is agreed, but the fund says it still needs internal investment committee approval, trustee clearance, conflict review, LP advisory committee discussion or investor consent. Founders then mistake fund governance for investor hesitation.

The best response is not irritation. It is planning. Ask the fund at term-sheet stage what approvals are still open and whether any related-party, side-letter, sector, valuation, follow-on reserve or concentration issue could trigger additional consent.

• Ask whether the fund is investing from the main scheme, a co-investment vehicle or an affiliate.
• Check whether any existing investor, director or advisor is related to the fund manager or sponsor.
• Ask whether the investment breaches sector, stage, geography or concentration limits in the PPM.
• Confirm whether side letters create special investor rights affecting the startup.
• Build consent timelines into the closing calendar.

Conflicted transactions founders should recognise

Conflicts can arise even when nobody is acting badly. A fund manager may have another portfolio company in the same sector. A sponsor affiliate may provide debt. A partner may sit on both sides of a transaction. An exit may be to a related buyer. A bridge round may favour one class of investors. These situations need disclosure and process.

How to protect the closing calendar

The founder should not sign a term sheet with a 15-day closing assumption if the fund needs a 30-day investor consent process. Ask for an approval map. List every decision maker: investment committee, trustee, sponsor, manager, LPAC, investors, tax counsel, FEMA counsel and portfolio conflict team.

Then convert that map into conditions precedent. If fund consent is outside the startup’s control, the startup should avoid open-ended exclusivity or hard obligations before the fund completes its approvals.

Documents founders should prepare

• Clean cap table and fully diluted shareholding.
• Board and shareholder approvals for the round.
• Disclosure of related parties, investor links and advisor roles.
• Existing SHA rights, ROFR, pre-emption and reserved matters.
• Material contracts and customer concentration details.
• ESOP pool status and grant history.
• Use of funds and valuation support.
• FEMA filings for past foreign investment.
• Conflict disclosures for directors and founders.

Important: consultation is not final law

As of 3 August 2026, the 30 June item remains a consultation entry on SEBI’s AIF page. Founders should not rewrite deal documents as if every proposal is already law. But they should expect fund counsel to be more sensitive to consent records, conflict disclosure and investor-approval mechanics because consultation papers often influence market behaviour before final amendments land.

In practical terms, the founder question is: “Does this fund have everything it needs to invest on the agreed date?” If the answer depends on investor consent, make that visible.

Questions to ask an AIF before signing

• Which scheme or vehicle will invest?
• Is the investment within the PPM strategy and concentration limits?
• Are any investor consents or LPAC approvals required?
• Are there side letters that affect confidentiality, reporting or exit?
• Is any manager, sponsor, associate or portfolio entity conflicted?
• Can the fund wire immediately after CP completion?
• What fund-level approvals are still pending?
• Will any co-investor or affiliate require separate documentation?

The Best CS Firm In India approach is to diligence the investor’s approval path as seriously as the investor diligences the company.

FAQs for founders

Does this affect angel investors?

It primarily concerns SEBI-regulated AIFs. Angel networks or individuals may have different approval processes unless investing through an AIF structure.

Can a fund consent issue kill a round?

Yes, if the fund cannot obtain required approvals or the transaction creates an unmanageable conflict. More often, it delays closing.

Should the SHA mention fund-level consent?

Usually fund-level consent is internal to the fund, but closing conditions and long-stop dates should reflect any pending approvals.

What is the founder’s best protection?

Ask approval-path questions before exclusivity, keep documents ready, and avoid promising a closing date that depends on invisible fund governance.